Liven Pharma Limited announced on Thursday its first successful export to the Arab region.
The company disclosed in its notice to the Pakistan Stock Exchange (PSX) on Thursday.
The company said that the order was received last year and it had been completed this year.
Last month, the company announced plans to raise Rs200 million via a rights issue to strengthen its financial position and support business expansion.
According to the disclosure, the company will issue 20 million ordinary shares at Rs10 per share — representing around 21.5% of its existing paid-up capital. This translates into 21.496 rights shares for every 100 ordinary shares held by shareholders at the close of the share transfer books.
Liven Pharma Limited was incorporated in Pakistan as a private Limited Company on October 21, 1991 and was converted into a public limited company on April 30, 1992, under the Companies Ordinance, 1984 (Repealed with the enactment of the Companies Act, 2017). The principal activity of the company is the manufacturing of pharmaceuticals and allied products.
Comments
Comments are closed for this article.